ACTIVE

CellCarta

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result7,7 M €-12,5 %over 1 year

Revenue79,9 M €+7,9 %over 1 year

Equity25,9 M €+42,4 %over 1 year

Workforce242,7 ETP+2,7 %over 1 year

Identity

Source · BCE/KBO

CellCarta is a Public limited company incorporated in 2001. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Antwerpen. It employs on average 242,7 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0474.654.355
Incorporation: 23/04/2001
Legal form: Public limited company
Registered office: Sint-Bavostraat 78
2610 Antwerpen · FlandreSee on map
Contributed capital: 1 062 000,00 €
Latest accounts: 31/12/2025
Average workforce: 242,7 ETP

Activities (NACE)

72109Research and experimental development on natural sciences and engineering· main 72190Other research and experimental development on natural sciences and engineering 73100Advertising 85141Pre-primary education 86901Other human health activities 86910Other human health activities

Joint committees (3)

207
330
33004

Contacts

3 public details availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	79,9 M €	+7.9%	74 M €	+26.3%	58,6 M €	+10.4%	53,1 M €	+23.9%	42,8 M €
EBITDA	14,4 M €	+11.5%	12,9 M €	+149%	5,2 M €	-18.7%	6,4 M €	+27.6%	5 M €
Operating result	11,7 M €	+10.5%	10,6 M €	+199%	3,5 M €	-30.9%	5,1 M €	+32.5%	3,9 M €
Net result	7,7 M €	-12.5%	8,8 M €	+922%	860,1 k €	+111%	-7,6 M €	-198%	7,7 M €
Balance sheet
Equity	25,9 M €	+42.4%	18,2 M €	+93.8%	9,4 M €	+10.1%	8,5 M €	-47.2%	16,1 M €
Total assets	60,5 M €	+4.5%	57,9 M €	+15.8%	50 M €	+12.8%	44,3 M €	+15.8%	38,3 M €
Cash	7,3 M €	-52.0%	15,2 M €	+68.0%	9 M €	+76.4%	5,1 M €	+28.7%	4 M €
Debts	21,5 M €	-14.8%	25,2 M €	-4.6%	26,4 M €	+4.0%	25,4 M €	+92.2%	13,2 M €
Other
Workforce	242,7 ETP	+2.7%	236,4 ETP	+5.1%	225,0 ETP	+9.0%	206,5 ETP	+19.4%	173,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Hendriks Consulting Company0832.653.047Represented by Dirk Hendriks	Managing director06/05/2019 → 14/05/2031Director06/05/2011 → 2014 accountsended
KOCKX-CONSULTING0882.632.197Represented by Mark Kockx	Managing director01/10/2006 → 11/03/2026Director06/05/2019 → 2019 accountsended
Elliot Miller	Director08/07/2025 → 08/07/2031
Joshua Schultz	Director06/02/2025 → 08/05/2030
Maurice Tenney III	Director30/08/2023 → 13/05/2026
Anthony L. Mattacchione	Director15/03/2022 → 09/03/2027
David Spaight	Director01/08/2019 → 14/05/2025

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Martin Leblanc	Managing director01/08/2019 → 2023 accounts
HistoGeneX Holding0643.686.060Represented by Kockx-Consulting BV vertegenwoordigd door Mark Kockx	Director01/03/2016 → 01/08/2019

Other companies at this address

Sint-Bavostraat 78 2610 Antwerpen

Company	CBE no.
Arsenal IO Belgium● Active	0726.786.752
HistoGeneX Holding● Active	0643.686.060

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	09/06/2026	25/09/2025	28/06/2024	31/08/2023	20/06/2022	27/05/2021
General meeting	13/05/2026	11/09/2025	08/05/2024	31/08/2023	11/05/2022	12/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	13/05/2026	09/06/2026	Dutch	PDF
Full model	31/12/2024	11/09/2025	25/09/2025	Dutch	PDF
Full model	31/12/2023	08/05/2024	28/06/2024	Dutch	PDF
Full model	31/12/2022	31/08/2023	31/08/2023	Dutch	PDF
Full model	31/12/2021	11/05/2022	20/06/2022	Dutch	PDF
Full model	31/12/2020	12/05/2021	27/05/2021	Dutch	PDF
Full model	31/12/2019	29/06/2020	16/07/2020	Dutch	PDF
Full model	31/12/2018	06/05/2019	03/06/2019	Dutch	PDF
Full model	31/12/2017	09/05/2018	07/06/2018	Dutch	PDF
Full model	31/12/2016	10/05/2017	09/06/2017	Dutch	PDF
Full model	31/12/2015	16/06/2016	15/07/2016	Dutch	PDF
Abridged model	31/12/2014	03/06/2015	26/06/2015	Dutch	PDF
Abridged model	31/12/2013	25/07/2014	05/09/2014	Dutch	PDF
Abridged model	31/12/2012	08/05/2013	07/06/2013	Dutch	PDF
Abridged model	31/12/2011	09/05/2012	06/06/2012	Dutch	PDF
Abridged model	31/12/2010	11/05/2011	12/07/2011	Dutch	PDF
Abridged model	31/12/2009	12/05/2010	10/06/2010	Dutch	PDF
Abridged model	31/12/2008	13/05/2009	09/06/2009	Dutch	PDF
Abridged model	31/12/2007	14/05/2008	11/06/2008	Dutch	PDF
Abridged model	31/12/2006	09/05/2007	06/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Hendriks Consulting Company0832.653.047Represented by Dirk Hendriks	Managing director06/05/2019 → 14/05/2031Director06/05/2011 → 2014 accountsended
KOCKX-CONSULTING0882.632.197Represented by Mark Kockx	Managing director01/10/2006 → 11/03/2026Director06/05/2019 → 2019 accountsended
Elliot Miller	Director08/07/2025 → 08/07/2031
Joshua Schultz	Director06/02/2025 → 08/05/2030
Maurice Tenney III	Director30/08/2023 → 13/05/2026
Anthony L. Mattacchione	Director15/03/2022 → 09/03/2027
David Spaight	Director01/08/2019 → 14/05/2025

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Martin Leblanc	Managing director01/08/2019 → 2023 accounts
HistoGeneX Holding0643.686.060Represented by Kockx-Consulting BV vertegenwoordigd door Mark Kockx	Director01/03/2016 → 01/08/2019

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates11/08/2026
Beëindiging van mandaat van bestuurder - Herbenoeming van de
PDF
Mandates12/01/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/06/2025
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/10/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/12/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/02/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/04/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/02/2022
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings19 filings

Mandates

Hendriks Consulting Company

KOCKX-CONSULTING

Elliot Miller

Joshua Schultz

Maurice Tenney III

Anthony L. Mattacchione

David Spaight

Martin Leblanc

HistoGeneX Holding

Klinisch bioloog Walter Verstrepen

Simon Scharpé

Michaël Knaapen

Show the 2 other mandates

2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031

CellCarta

Sint-Bavostraat 78, 2610 Wilrijk (Antwerp)

Managing directorDirector

Managing director

Director

Managing director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Sint-Bavostraat 78, 2610 Wilrijk (Antwerp)Current	accounts 2021 → 2025	Accounts 2025 · 2026-00154541

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
CellCartaCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00154541

Events

2025
Annual accounts 20257,7 M €↓
08/07/2025
nominationElliott Miller · bestuurder
06/02/2025
nominationJoshua Schultz · bestuurder
2024
Annual accounts 20248,8 M €↑
2023
Annual accounts 2023860,1 k €↑
30/08/2023
nominationMaurice Tenney III · bestuurder
30/08/2023
nominationKristien Verhoeven · dagelijks bestuurder
18/01/2023
nominationPricewaterhouseCoopers Bedrijfsrevisoren BV · commissaris
2022
Annual accounts 2022-7,6 M €↓
15/03/2022
nominationAnthony L. Mattacchione · bestuurder
2021
Annual accounts 20217,7 M €↑
2019
Annual accounts 20194 M €↓
2018
Annual accounts 20184,4 M €↑
2017
Annual accounts 20172,5 M €↓
2016
Annual accounts 20162,8 M €↑
2015
Annual accounts 20151,7 M €↑
2014
Annual accounts 20141 M €↑
2013
Annual accounts 2013-1,2 M €↓
2012
Annual accounts 2012113,6 k €↑
2011
Annual accounts 201156,5 k €↓
2010
Annual accounts 20101,1 M €↓
2009
Annual accounts 20091,3 M €↑
2008
Annual accounts 2008703,7 k €↓
2007
Annual accounts 2007717,1 k €↑
2006
Annual accounts 2006387,5 k €
23/04/2001
IncorporationPublic limited company

CellCarta

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events